Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts

Telmisartan attenuates SMC proliferation via PPARγ activity and suppresses neo-intimal hyperplasia after transplantation. Telmisartan may be useful for suppressing chronic allograft rejection.